Bartlett & Co Wealth Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
SRC
CIEC
FIA
YIH
AA
SIM
COPPSERS
CWP
LSERS
Bartlett & Co Wealth Management's AVNS Position: Q2 2026 in Review
Bartlett & Co Wealth Management sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 21 shares — an estimated $518 sold.
Bartlett & Co Wealth Management first reported a position in AVNS in Q1 2018 and held it in 30 quarters. The position peaked at $83.6K in Q3 2018. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.
- Bartlett & Co Wealth Management reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
- Bartlett & Co Wealth Management sold 21 Avanos Medical shares in Q2 2026, an estimated $518.
- Bartlett & Co Wealth Management first reported a position in Avanos Medical in Q1 2018 and held it in 30 quarters.
- Bartlett & Co Wealth Management's Avanos Medical position peaked at $83.6K in Q3 2018.
- 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.